Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

How FRE Nicotine Pouches landed landmark sponsorship deal with UFC and more

Published

on

How FRE Nicotine Pouches landed landmark sponsorship deal with UFC and more

In between the thrill of the bouts on fight night, you may notice a new partner listed on the canvas of a UFC octagon: FRE Nicotine Pouches. 

In a first-of-its-kind collaboration, FRE became the “official nicotine pouch partner” of UFC and the rest of TKO Group Holdings, Inc. (TKO) affiliated properties, including Zuffa Boxing, PBR (Professional Bull Riding), and UFC BJJ, as well as IMG-owned World’s Strongest Man and Formula Drift. 

Advertisement

FRE has been quietly building a sports portfolio that reaches those performance-obsessed audiences across the country, but the announcement of the partnership with TKO last month was a landmark title sponsorship. 

CLICK HERE FOR MORE SPORTS COVERAGE ON FOXBUSINESS.COM

UFC fight with FRE Nicotine Pouches branding

TKO Group Holdings, Inc. and FRE Pouches, a consumer product from Turning Point Brands, partnered to become UFC’s “official nicotine pouch.” (FRE Nicotine Pouches / Fox News)

UFC became the first major U.S. sports property to have an “official nicotine pouch” partner, making this a deal that changes the landscape of a category that will have an estimated $50 billion market by 2033. 

Summer Frein, chief revenue officer at Turning Point Brands, the branded consumer products company that markets and distributes products, including alternative smoking accessories, spoke with Fox Business about how FRE wanted to get into sports. And TKO’s properties, especially UFC, made too much sense.  

Advertisement

“Obviously, first and foremost, we wanted to pick something that aligns with our brand, and our tagline is ‘Own Your Edge.’ When you think about people who own their edge, sports immediately come to mind. And when you think about TKO — I said this to someone last week — where the hell do you own your edge more than knocking someone out in an octagon,” Frein said in a recent interview. 

UFC, BUD LIGHT TEAM UP TO MAKE ALREADY HIGHLY ANTICIPATED SUMMER OF FIGHTS THAT MUCH BETTER: ‘A FAN DELIGHT’

“The consumers who are at the events overlap with our consumer base very directly, both from an adult nicotine consumer perspective, but just the characteristics of them. What they believe in, what they embody (has) a lot of overlap with us as well in terms of being competitive, performance-driven and that sort of thing.”

The UFC has an audience that is over 90% adults, 21 years or older, making it an ideal platform for responsible marketing of adult consumer products like nicotine pouches. But, from an athlete’s perspective, research into how nicotine could enhance sports performance has been abundant. 

Advertisement

Smokeless tobacco has been widely used by athletes to enhance performance, with nicotine serving as a central nervous system stimulant among other anatomic effects. And while nicotine had a bad reputation due to its correlation with tobacco-based products like cigarettes, the stimulant wasn’t the cause of toxic health consequences. Of course, it remains an addictive chemical.

The growth of the global nicotine pouch market reached roughly $4.3 billion in 2025, and it’s only going to surge from there. FRE has moved fast to establish itself before it fully matures, and a deal like this with TKO proves that. 

FRE Nicotine Pouches partnership with TKO

FRE Nicotine Pouches became the “official nicotine pouch” of different TKO Group Holdings, Inc. properties, including UFC and Zuffa Boxing. (FRE Nicotine Pouches / Fox News)

“We started off with PBR last year. We rolled into some NASCAR and ARCA Series racing, and all of those foundational elements gave us the confidence that we were heading in the right direction. Sports made a lot of sense for us,” Frein added. 

“I think [TKO was] also looking for partners and consumers that had overlap, so we were building upon each other there. The consumers expect that. You have seen UFC consumers and fans at events. They ride for that brand. So, if they partner with brands that don’t make sense, I don’t think those fans will be quiet about that. I think our brand made a lot of sense for that reason, too.”

Advertisement

Frein pointed out how FRE sets itself apart for its consumers with its variety of flavors, and, more importantly, nicotine strengths. FRE pouches go from three milligrams up to 15, a strength not many competitors have in their product. No matter where a consumer may be on a nicotine pouch journey, FRE prides itself on that variety to help provide consumers with how they wish to have the product. 

“Consumers told us they use nicotine and use these pouches, in particular, in their life for a variety of reasons. One is to transition off of products they don’t want to use anymore, different nicotine products they don’t want to use anymore. They feel like this is a better option for them – more discreet, less judgment, that sort of thing. Then, we hear them say what you’re saying. They use it for moments of their day that they find to be helpful to them,” Frein explained. 

FRE has also listened to its customers when it comes to the pouch itself. The pouches feature a pre-primed moisture technology pouch that Frein says consumers “prefer.” Their variety also goes into the pouch count, offering 20-count tins or 100-count “Mega Packs.”

And as Frein mentioned, FRE’s push into sports goes beyond its work with TKO. It recently partnered with 23XI Racing, Michael Jordan’s auto racing company, and driver Riley Herbst for select NASCAR Cup Series races. It also signed as the “official nicotine sponsor” for Taylor Reimer Racing across four ARCA Menards Series events in 2026. 

Advertisement
FRE branding on NASCAR with 23XI Racing

FRE Nicotine Pouches branding on a 23XI Racing NASCAR vehicle for the NASCAR Cup Series. (FRE Nicotine Pouches / Fox News)

CLICK HERE FOR MORE SPORTS COVERAGE ON FOXBUSINESS.COM

As tobacco-less nicotine products have been reframed from a legacy habit to a deliberate, performance-based choice, FRE has made a calculated bet on sports, and partnering with TKO makes the future exciting from a business perspective.  

“I think what the partnership with TKO and NASCAR and Taylor Reimer in the ARCA Series has done for us is open people’s minds,” Frein said. 

“Open doors, given us credibility as a brand and as an industry that we can make it work. We’re going to have a seat at the table. We’re going to market effectively and responsibly, frankly. So, I imagine that, just given the prior piece of the conversations around athletes and them thinking differently and having this a part of their lives, it will open doors to other avenues.”

Advertisement

Follow Fox News Digital’s sports coverage on X and subscribe to the Fox News Sports Huddle newsletter.

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Rich Paul Sparks Debate With Bold Claim on Jordan-Pippen Dynasty and NBA Titles

Published

on

Bronny James

NEW YORK — NBA agent Rich Paul has ignited a fierce debate over basketball’s greatest dynasty by asserting that Scottie Pippen’s contributions to the Chicago Bulls’ six championships in the 1990s were equal to those of Michael Jordan, suggesting the franchise icon would have zero rings without his longtime teammate.

Paul, best known as the longtime representative for LeBron James, made the comments during a recent episode of the “Game Over” podcast with Max Kellerman. The remarks, which quickly went viral, have divided fans, analysts and former players, reigniting discussions about team success, individual greatness and the delicate balance required for NBA championships.

“I think Scottie’s rings are the same as Michael Jordan’s. He was the most impactful player on the team. If you unplug Scottie Pippen off that team, Jordan is 0-6,” Paul said on the podcast.

The statement highlights Pippen’s versatile skill set — a 6-foot-8 forward with elite defense, playmaking ability and a 7-foot-3 wingspan who could guard multiple positions and initiate offense. Paul pointed to the Bulls’ depth of All-Defensive players and argued that Pippen’s two-way impact formed the foundation of their success from 1991 to 1998.

Advertisement

Pippen, a seven-time All-Star and Hall of Famer, is widely praised as one of the finest two-way players in league history. He earned six championships alongside Jordan, was named to the NBA’s All-Defensive First Team eight times and finished as the Bulls’ leader in assists and steals during much of the dynasty. Yet Jordan’s unparalleled scoring, competitive fire and clutch performances have cemented him as the face of those title teams.

The reaction was swift and passionate. Stephen A. Smith and other commentators addressed the take on ESPN’s “First Take,” with many pushing back on the notion that Jordan’s greatness depended so heavily on one teammate. Critics argue Jordan’s six Finals MVP awards and his ability to elevate teammates underscore his singular dominance.

Supporters of Paul’s view point to the 1993-94 season, when Jordan briefly retired to pursue baseball. Pippen led the Bulls to 55 wins and a deep playoff run, losing in the Eastern Conference semifinals to the New York Knicks. That performance, they contend, demonstrates Pippen’s value when carrying a heavier load.

Paul’s comments also extended to the broader supporting cast. He noted the presence of players like Dennis Rodman, who joined for the second three-peat, and the defensive-minded roster constructed around Jordan. Replacing Pippen with a generic All-Star, Paul suggested, would not have yielded the same results due to Pippen’s unique combination of size, skill and basketball IQ.

Advertisement

The controversy arrives amid ongoing debates about legacy and comparisons between eras, particularly involving James, whom Paul represents. Some analysts, including former NBA center Kendrick Perkins, suggested Paul’s remarks could inadvertently harm James’ standing in the greatest-of-all-time conversation by appearing to diminish Jordan’s individual achievements.

“This is where he has to stop, this is where he starts to hurt LeBron James GOAT case,” Perkins said on his podcast.

Jordan, who has largely stayed out of public debates in recent years, has not commented directly on Paul’s take. The six-time champion has historically credited teammates, including Pippen, for their roles in the Bulls’ success while maintaining his own drive as the primary factor.

Basketball historians note the Bulls’ dynasty was built on Phil Jackson’s triangle offense, elite scouting and a perfect storm of talent. Jordan’s scoring average of 30.1 points per game in the Finals, combined with his defensive improvements, created a winning formula. Yet the system’s reliance on complementary pieces underscores Paul’s broader point about team construction.

Advertisement

Pippen himself has been vocal in recent years about feeling underappreciated, particularly regarding his salary during the dynasty and his contributions beyond the spotlight. In his autobiography and interviews, he has discussed the physical toll of guarding the opponent’s best player while facilitating for Jordan.

The timing of Paul’s comments coincides with heightened NBA discourse as the 2026 Finals approach, featuring teams emphasizing modern two-way versatility similar to what Pippen exemplified. Today’s game rewards length, switchable defenders and multi-positional playmakers, traits that defined Pippen’s prime.

Analysts have drawn parallels to other iconic duos. Magic Johnson and Kareem Abdul-Jabbar, Shaquille O’Neal and Kobe Bryant, and more recently Stephen Curry and Kevin Durant all required chemistry and complementary skills. Few, however, matched the sustained dominance of Jordan and Pippen across two three-peats.

Paul’s perspective as a super-agent offers insight into roster building. His Klutch Sports Group prioritizes player empowerment and long-term career management, often emphasizing supporting casts around stars. His defense of Pippen aligns with arguments that undervalued role players and secondary stars deserve greater recognition for championship success.

Advertisement

Social media erupted with divided opinions. Some users praised Paul for highlighting Pippen’s overlooked excellence, while others accused him of revisionist history to elevate modern narratives. Clips from the podcast amassed millions of views across platforms within days.

Former Bulls players and coaches have offered mixed responses in interviews. Some emphasize Jordan’s leadership and killer instinct as irreplaceable, while acknowledging Pippen’s steady excellence prevented defensive collapses.

The debate extends beyond nostalgia. It touches on how success is measured in team sports — individual statistics versus intangible impact, regular-season dominance versus playoff clutch moments, and narrative control in legacy building.

Jordan’s six championships came with a perfect Finals record, an achievement that remains a cornerstone of his legend. Pippen’s career, while Hall of Fame worthy, included later stints with the Houston Rockets and Portland Trail Blazers that yielded no additional titles.

Advertisement

As the conversation continues, it serves as a reminder of basketball’s rich history and the subjective nature of evaluating greatness. Paul’s provocative take has succeeded in prompting reevaluation of the Bulls era, even if many reject his core premise.

For Pippen, now in his 60s, the renewed attention underscores his enduring legacy. Whether viewed as Jordan’s equal in impact or as the ultimate complementary superstar, his place among the all-time greats appears secure.

The episode highlights how sports discourse evolves with new voices challenging traditional views. In an era of podcasts and instant analysis, bold claims like Paul’s ensure legends of the game remain relevant to younger generations discovering the Jordan-Pippen era through highlights and documentaries.

Ultimately, the six championships belong to the entire organization — players, coaches, executives and fans. Paul’s comments, while polarizing, invite deeper appreciation of the supporting pieces that enable transcendent talent to shine. As the NBA moves forward, the lessons from that dynasty continue influencing team construction and player evaluation.

Advertisement
Continue Reading

Business

BHP tests marine biofuel on Pilbara iron ore shipping route

Published

on

BHP tests marine biofuel on Pilbara iron ore shipping route

A bulk carrier fueled with cooking oil and animal fat will set sail for Port Hedland under a trial backed by BHP and the Global Centre for Maritime Decarbonisation.

Continue Reading

Business

AEW UK REIT buys interest rate cap ahead of 2027 refinancing

Published

on


AEW UK REIT buys interest rate cap ahead of 2027 refinancing

Continue Reading

Business

Why Labour’s Brexit focus has shifted from Leavers to Remainers

Published

on

Why Labour's Brexit focus has shifted from Leavers to Remainers

Although on Tuesday Reeves, in contrast, stressed that the red lines set out in Labour’s manifesto still stand, the chancellor has now clearly signalled a shift. She indicated in her Mais lecture that, wherever it was in Britain’s interest to do so, the government wants to align the UK’s regulatory regime with that of the EU in more areas.

Continue Reading

Business

Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspension

Published

on

Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspension
Shares of Concord Biotech surged as much as 8.46% on Wednesday, hitting an intraday high of Rs 1,264.90, after the company announced that it had received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL.

According to the company’s regulatory filing, the approved product is an antimetabolite immunosuppressant used for the prophylaxis of organ rejection in adult and pediatric patients aged three months and older undergoing kidney, heart, or liver transplants. The medication is administered in combination with other immunosuppressive therapies.

The company highlighted that the approval aligns with its long-term growth strategy and is expected to strengthen its presence in the U.S. pharmaceutical market. Industry estimates suggest that the U.S. market for Mycophenolate Mofetil is valued at approximately US$30 million, providing Concord Biotech with a significant commercial opportunity.

In its disclosure, Concord Biotech stated that the approval was granted by the U.S. Food and Drug Administration (USFDA) and pertains specifically to Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL. The company noted that the approval will enhance its product portfolio and support expansion across both U.S. and international markets. There were no instances of withdrawal, cancellation, or suspension of the approval, and therefore no associated penalties or adverse financial impact.

Advertisement

Stock Performance and Valuation

Despite Tuesday’s rally, Concord Biotech’s stock remains significantly below its 52-week high of Rs 2,150. The stock’s 52-week low stands at Rs 987. The company currently commands a market capitalization of approximately Rs 12,200 crore.

On the valuation front, the stock is trading at a price-to-earnings (P/E) ratio of 42.56 and a price-to-book (P/B) ratio of 6.13.

Technical Indicators

The stock’s Relative Strength Index (RSI-14) stands at 56.2, indicating neutral-to-positive momentum. An RSI reading below 30 is generally considered oversold, while a reading above 70 signals overbought conditions.


From a trend perspective, Concord Biotech is trading above six of its eight key simple moving averages (SMAs), reflecting a broadly positive technical setup.

Shareholding Pattern

Institutional investor activity remained mixed during the March 2026 quarter. Foreign Institutional Investors (FIIs) marginally increased their stake in Concord Biotech to 7.79% from 7.58% in the previous quarter, reflecting continued investor interest. In contrast, mutual funds trimmed their holdings, reducing their stake from 4.44% to 4.30% during the same period.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Advertisement
Continue Reading

Business

Leaders Of Today, Leaders Of Tomorrow: Convertible Opportunity In Focus

Published

on

Leaders Of Today, Leaders Of Tomorrow: Convertible Opportunity In Focus

Calamos Investments is a diversified global investment firm offering innovative investment strategies including U.S. growth equity, global equity, convertible, multi-asset and alternatives. The firm offers strategies through separately managed portfolios, mutual funds, closed-end funds, private funds, an exchange traded fund and UCITS funds. Clients include major corporations, pension funds, endowments, foundations and individuals, as well as the financial advisors and consultants who serve them. Headquartered in the Chicago metropolitan area, the firm also has offices in London, New York and San Francisco.  For more information, please visit www.calamos.com.

Continue Reading

Business

Europe's Infotech Capital Raising Drops To $804.7M In April

Published

on

Europe's Infotech Capital Raising Drops To $804.7M In April

Europe's Infotech Capital Raising Drops To $804.7M In April

Continue Reading

Business

Plan for homes on 14 acres of ‘productive farmland’ sparks hundreds of objections

Published

on

Business Live

Officers say the benefits of Wain Homes scheme would outweigh the harms

Wain Homes North West wants planning permission to build 122 homes on land east of Prescot Road in Aughton, near Ormskirk.

The Wain Homes North West plan for land east of Prescot Road in Aughton(Image: Wain Homes)

Plans to build homes on 14 acres of ‘productive farmland’ in Lancashire have prompted more than 450 people to contact a council, with nearly all of them objecting.

Advertisement

Wain Homes North West wants planning permission to build 122 homes on land east of Prescot Road in Aughton, near Ormskirk.

But objectors say the soil there is high quality and should stay used for farming. Others have fears that local health services would be over-stretched with extra people living in the new homes, or concerns about extra traffic or flooding.

Wain Homes is proposing a mix of new homes, from one-bedroom apartments to five-bedroom detached houses. New access is planned for cars, cyclists and pedestrians. It says the estate will be well-planned, will echo local architecture styles and will be ‘easily absorbed’ into its immediate context. And the new development would help address the need for local housing.

West Lancashire Council’s planning committee will consider the plan this week. But councillors are being advised by planning officers to defer it to a top officer and leading councillor to consider approval, subject to planning conditions and an agreement about cash contributions to local NHS services and amenities

Advertisement

The many objectors include Aughton Parish Council which ‘strongly opposes’ the housing plan application, having listened to local residents’ views. The parish said: “West Lancashire Council’s current local plan has two years to run so it would be premature to release ‘safeguarded’ land without justification. As far as we are aware, the current local plan has not under-delivered and housing targets are being achieved.

“This site has always been, and still is, in agricultural use and is identified as grades 2 and 3 in best and most versatile (BMV) measurements. National planning policy clearly states that BMV land should not be developed unless absolutely necessary. The loss of this land for housing would be contrary to national policy and result in the permanent loss of productive farmland.”

Grade 1 is the most productive soil, classed as ‘excellent’. Grade 2 is ‘very good’ and grade 3 is ‘good to moderate’, according to Natural England guidance for planning applications.

Aughton Parish Council also said the proposed development would represent a ‘severe and irreversible environmental loss particularly in respect of wildlife and protected species’.

Advertisement

Regarding local traffic, objectors say other possible housing developments along Prescot Road and Parrs Lane would create an unacceptable impact on road safety and the overall impact on roads would be ‘severe’.

Wain Homes North West wants planning permission to build 122 homes on land east of Prescot Road in Aughton, near Ormskirk.

The Wain Homes North West plan for land east of Prescot Road in Aughton(Image: Wain Homes)

However, West Lancashire planning officers say the benefits of housing would outweigh the harms, such as the loss of farmland. And measures could be taken to protect and re-use soil and to help hedges.

They believe borough councillors should delegate granting permission to the council’s deputy chief executive with a leading planning committee member, subject to an agreement with Wain Homes. Details to come should include numbers of affordable housing and specialist housing, public open space and biodiversity gains.

Planning officers have suggested Wain Homes pay £44,000 for open space provision elsewhere, £129,000 towards expanding or building an alternative NHS premises for Aughton Surgery and contribute over £400,000 towards road and transport needs.

Advertisement

To find all the planning applications, traffic diversions, road layout changes, alcohol licence applications and more in your community, visit the Public Notices Portal.

Continue Reading

Business

Which Fast-Food Stock Offers Better Value for Investors in 2026?

Published

on

wendy's

NEW YORK — As the fast-food industry navigates shifting consumer preferences, inflationary pressures and intense competition in 2026, investors are weighing McDonald’s Corp. against Wendy’s Co. to determine which chain offers stronger potential returns amid ongoing value wars and menu innovation battles.

McDonald’s, the larger and more established player, has maintained relative stability with shares trading around $276-$311, while Wendy’s has faced significant headwinds, with shares hovering near $7.21 after challenging same-store sales and planned U.S. restaurant closures.

Analysts generally favor McDonald’s for its global scale, consistent dividends and defensive qualities, while Wendy’s appeals to those seeking higher yield and potential recovery upside despite near-term pressures.

McDonald’s Defensive Strength

Advertisement

McDonald’s has demonstrated resilience in 2026 with value-focused initiatives helping offset softer traffic trends. The company reported solid first-quarter results, with global comparable sales growth and operating margin expansion driven by operational efficiencies and strategic pricing.

Its extensive international footprint, digital ordering advancements and consistent innovation in menu items have supported steady performance. Analysts maintain a Moderate Buy consensus with average price targets around $333-$335, implying meaningful upside from current levels.

The company continues expanding its restaurant count globally while focusing on core strengths like breakfast and value meals. Strong free cash flow supports a reliable dividend, making it attractive for income-oriented investors seeking stability in the consumer discretionary sector.

Wendy’s Struggles and Turnaround Efforts

Advertisement

Wendy’s has encountered more difficult conditions, reporting its weakest U.S. same-store sales in 20 years amid value menu missteps and competitive pressure from McDonald’s. The company plans to close approximately 240 U.S. locations in 2026 as part of efficiency initiatives while focusing on international growth, including a major franchise agreement in China.

Despite challenges, Wendy’s offers a high dividend yield near 7% and trades at lower valuation multiples. Analysts assign a Hold to Reduce consensus with average price targets around $8.00-$8.56, suggesting modest upside potential.

Management has reaffirmed 2026 guidance with flat systemwide sales growth and adjusted EBITDA between $460 million and $480 million. Turnaround efforts center on operational improvements, menu optimization and international expansion to offset domestic pressures.

Key Comparison Factors

Advertisement

Scale and Market Position: McDonald’s dominates with thousands more locations worldwide and stronger brand recognition. Wendy’s maintains a smaller but differentiated presence focused on fresh beef and breakfast offerings.

Financial Performance: McDonald’s shows more consistent revenue and earnings growth. Wendy’s faces margin pressures and negative same-store sales trends but benefits from a higher dividend yield that appeals to income investors.

Growth Outlook: McDonald’s benefits from global scale and digital initiatives. Wendy’s is betting on cost efficiencies, selective closures and overseas expansion for recovery, though 2026 guidance remains cautious.

Risk Profile: McDonald’s offers lower volatility and defensive characteristics. Wendy’s carries higher risk due to execution challenges but potential reward if turnaround measures succeed.

Advertisement

Broader Industry Context

The fast-food sector faces consumer trade-down behavior amid economic uncertainty. Value menus have become critical battlegrounds, with McDonald’s aggressive pricing helping maintain traffic. Both companies contend with rising labor and commodity costs, though McDonald’s scale provides advantages in supplier negotiations.

Digital ordering, loyalty programs and menu innovation remain key differentiators. International markets offer growth opportunities, particularly in Asia, where Wendy’s is expanding aggressively through franchising.

Investment Considerations for 2026

Advertisement

Conservative investors seeking stability and reliable dividends may prefer McDonald’s, which continues delivering consistent performance despite industry challenges. Those comfortable with higher risk and seeking elevated yield could consider Wendy’s, particularly if turnaround initiatives gain traction.

Portfolio allocation matters significantly. Many investors maintain exposure to both names or broader restaurant ETFs to balance defensive qualities with recovery potential. Long-term horizons favor companies with strong brands and adaptable business models.

Neither stock is without risks. McDonald’s faces valuation concerns at current levels, while Wendy’s contends with execution risks and domestic market pressures. Macroeconomic factors including consumer spending, inflation and interest rates will influence both companies.

Final Outlook

Advertisement

McDonald’s currently appears the stronger choice for most investors in 2026, offering better stability, global reach and consistent execution. Wendy’s provides higher yield and potential upside for those bullish on its recovery strategy, though near-term challenges persist.

Market conditions remain fluid, and investors should monitor quarterly results closely. Thorough due diligence and consideration of individual risk tolerance remain essential before making investment decisions.

Continue Reading

Business

USA Rare Earth, Inc. (USAR) Presents at 46th Annual William Blair Growth Stock Conference – Slideshow

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

USA Rare Earth, Inc. (USAR) Presents at 46th Annual William Blair Growth Stock Conference – Slideshow

Continue Reading

Trending

Copyright © 2025